The Patent Finder

James Black Foundation Limited

Also on record
Records under this name other than patents James Black Foundation Limited holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to James Black Foundation Limited

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 6,479,531Gastrin and cholecystokinin receptor ligands
Lapsed on the fee record
Ended Nov 12, 2010 · USPTO record
Lapsed on the fee recordEnded Nov 12, 2010USPTO record
US 7,105,558Gastrin and cholecystokinin receptor lignads (iv)
Lapsed on the fee record
Ended Sep 12, 2010 · USPTO record
Lapsed on the fee recordEnded Sep 12, 2010USPTO record
US 6,407,132Substituted imidazole derivatives and their use as histamine H3 receptor ligands
Lapsed on the fee record
Ended Jun 18, 2010 · USPTO record
Lapsed on the fee recordEnded Jun 18, 2010USPTO record
US 7,034,048Gastrin and cholecystokinin receptor ligands (III)
Lapsed on the fee record
Ended Apr 25, 2010 · USPTO record
Lapsed on the fee recordEnded Apr 25, 2010USPTO record
US 6,355,6651H-4(5)-substituted imidazole derivatives, their preparation and their use as histamine H3 receptor ligands
Lapsed on the fee record
Ended Mar 12, 2010 · USPTO record
Lapsed on the fee recordEnded Mar 12, 2010USPTO record
US 6,956,053Pyrazole derivatives and their use as gastrin and cholecystokin receptor ligands
Lapsed on the fee record
Ended Oct 18, 2009 · USPTO record
Lapsed on the fee recordEnded Oct 18, 2009USPTO record
US 6,878,734Gastrin and cholecystokinin receptor ligands(II)
Lapsed on the fee record
Ended Apr 12, 2009 · USPTO record
Lapsed on the fee recordEnded Apr 12, 2009USPTO record
US 6,878,736Histamine H3 receptor ligands
Lapsed on the fee record
Ended Apr 12, 2009 · USPTO record
Lapsed on the fee recordEnded Apr 12, 2009USPTO record
US 6,159,994Histamine H.sub.3 receptor ligands
Lapsed on the fee record
Ended Dec 12, 2008 · USPTO record
Lapsed on the fee recordEnded Dec 12, 2008USPTO record
US 6,080,871Sulfonamides and sulfamides as H.sub.3 receptor antagonists
Lapsed on the fee record
Ended Jun 27, 2008 · USPTO record
Lapsed on the fee recordEnded Jun 27, 2008USPTO record
10 of 20 patents shown.
Pro members see all 20.
Pro members: see all 20 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited